title: Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma.
abstract: This article contains data on clinical endpoints (Peak Flow Expiratory Rate, fractional exhaled nitric oxide and total IgE serum levels) and plasma pharmacokinetic parameters concerning the use of the oral CRTh2 antagonist QAW039 (fevipiprant) in mild to moderate asthma patients. Information on experimental design and methods on how this data was obtained is also described. Further interpretation and discussion of this data can be found in the article "The oral CRTh2 antagonist QAW039 (fevipiprant): a phase II study in uncontrolled allergic asthma" (Erpenbeck et al., in press) [1].
authors.affiliation: Novartis Pharma AG, Basel, Switzerland.
authors.forename: Veit J
authors.initials: VJ
authors.lastname: Erpenbeck
authors.affiliation: Clinic of Allergy & Asthma, Medical University Sofia, Sofia, Bulgaria.
authors.forename: Todor A
authors.initials: TA
authors.lastname: Popov
authors.affiliation: NEMRA, North Dartmouth, MA, United States.
authors.forename: David
authors.initials: D
authors.lastname: Miller
authors.affiliation: Allergy & Immunology, Allergy and Asthma Specialists Medical Group and Research Center, CA, United States.
authors.forename: Steven F
authors.initials: SF
authors.lastname: Weinstein
authors.affiliation: Allergy & Asthma, California Allergy and Asthma Medical Group Inc, CA, United States.
authors.forename: Sheldon
authors.initials: S
authors.lastname: Spector
authors.affiliation: Novartis Pharma AG, Basel, Switzerland.
authors.forename: Baldur
authors.initials: B
authors.lastname: Magnusson
authors.affiliation: Novartis Pharmaceuticals, Horsham, United Kingdom.
authors.forename: Wande
authors.initials: W
authors.lastname: Osuntokun
authors.affiliation: Novartis Pharmaceuticals, Horsham, United Kingdom.
authors.forename: Paul
authors.initials: P
authors.lastname: Goldsmith
authors.affiliation: Novartis Pharma AG, Basel, Switzerland.
authors.forename: Markus
authors.initials: M
authors.lastname: Weiss
authors.affiliation: INSAF, Respiratory Research Institute GmbH, Wiesbaden, Germany.
authors.forename: Jutta
authors.initials: J
authors.lastname: Beier